NASDAQ:IRMD
Iradimed Corp.
Iradimed Corp.'s revenue grew 14.4% in fiscal 2025 to $83.8M while operating margin rose to 31.2%. Free cash flow was $17.2M, 20.5% of revenue, and the diluted share count rose 0.5%.Summary generated from Iradimed Corp.'s SEC filings. Latest annual report filed Mar 6, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$83.8M
Revenue growth+14.4%
Revenue, 5-yr CAGR+21.5%
Gross margin76.7%
Operating margin31.2%
Net margin26.8%
ROICn/a
Return on equity24.8%
Debt / equityn/a
Free cash flow$17.2M
FCF margin20.5%
Share count change+0.5%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 42 | 53 | 66 | 73 | 84 |
| Operating income | 10 | 16 | 20 | 22 | 26 |
| Net income | 9 | 13 | 17 | 19 | 22 |
| Free cash flow | 11 | 9 | 6 | 18 | 17 |
Recent filings
- 4Insider transaction report
Sep 25, 2026 - 4Insider transaction report
Sep 8, 2026 - 8-K/AAmended results of operations and financial condition
Aug 18, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Jul 31, 2026 - 8-KOther events
Jul 31, 2026 - 8-KResults of a shareholder vote
Jun 24, 2026 - 10-QQuarterly report for the period ended Mar 31, 2026
May 1, 2026 - 8-KResults of operations and financial condition
May 1, 2026